Research

LIke ThisLIke ThisLIke This

2013

Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach.
Lee MN, Roy M, Ong S-E, Mertins P, V A-C, Li W, Dotiwala F, Sen J, Doench JG, Orzalli MH, Kramnik I, Knipe DM, Lieberman J, Carr SA, and Hacohen N.
Nature Immunology (2013), Volume: 17, Pages: 179-185. (PDF)

Arf-like GTPase Arl8b regulates lytic granule polarization and natural killer cell-mediated cytotoxicity.

Tuli A, Thiery J, James AM, Michelet X, Sharma M, Garg S, Sanborn KB, Orange JS, Lieberman J, Brenner MB.
Mol Biol Cell (2013), Volume: 24, Issue: 23, Pages: 3721-35. (PDF)

Micromanaging Hepatitis C Virus.
Lieberman J and Sarnow P.
The New England Journal of Medicine (2013). (PDF)

Efficient and specific gene knockdown by small interfering RNAs produced in bacteria.
Huang L, Jin J, Deighan P, Kiner E, McReynolds L, and Lieberman J.
Nature Biotechnology (2013). (PDF)

Live or let die: posttranscriptional gene regulation in cell stress and cell death.
Thomas MP and Lieberman J.
Immunological Reviews (2013), Volume: 253, Pages: 237-252. (PDF)

Durable Knockdown and Protection from HIV Transmission in Humanized Mice Treated With Gel-formulated CD4 Aptamer-siRNA Chimeras.
Wheeler LA, Vrbanac V, Trifonova R, Brehm MA, Gilboa-Geffen A, Tanno S, Greiner DL, Luster AD, Tager AM and Lieberman J.
Molecular Therapy (2013). (PDF)

A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cells.
Fabio Petrocca, Gabriel Altschuler, Shen Mynn Tan, Marc L. Mendillo, Haoheng Yan, D. Joseph Jerry, Andrew L. Kung, Winston Hide, Tan A. Ince, Judy Lieberman.
Cancer Cell (2013), Volume: 24, Issue: 2, Pages: 182-196. (PDF)

Production of highly potent recombinant siRNAs in Escherichia coli.
Huang L, Lieberman J.
Nature Protocols (2013), Volume: 8, Issue: 12, Pages: 2325-2336. (PDF)
LIke ThisLIke ThisLIke This
Close